Skip to main content

Table 2 Patients’ subgroups based on WHO Classification 2016

From: Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients

Subgroups

Number of patients

Normal cytogenetics

Abnormal cytogenetics

MDS-MLD

38 (36.89%)

22

16

MDS-SLD

28 (18.44%)

17

11

MDS-EB

MDS- EB-1

15 (14.56%)

11

4

MDS-EB -2

11 (10.67%)

5

6

MDS with isolated del(5q)

4 (3.88%)

0

4

MDS-RS

3 (2.91%)

1

2

MDS-U

4 (3.88%)

3

1

  1. MDS-MLD MDS with multilineage dysplasia, MDS-SLD MDS with single lineage dysplasia, MDS-EB MDS with excess blasts, MDS-RS MDS with ring sideroblasts, MDS-U MDS unclassifiable
Back to article page

Molecular Cytogenetics

ISSN: 1755-8166